New research presented today (Wednesday) at the Federation of European Neuroscience Societies (FENS) Forum 2026 has ...

A drug that showed promise in treating a sleep disorder could potentially help slow symptoms, experts say.

Kenai Therapeutics, a clinical-stage biotechnology company pioneering next generation approaches to cure neurological conditions, today announced the completion of enrollment for the REPLACE™ Phase 1b ...

Parkinson's disease (PD) is the second most common form of neurodegenerative disease and afflicts more than 10 million people ...

A study published in Cannabis and Cannabinoid Research examined the effects of medical cannabis on patients diagnosed with ...

Stacked appointments, new medications and meeting with the requirements of insurance policies are routine for those living with Parkinson’s disease. In rural states like Wyoming, patients ...

Parkinson’s disease is a long-term brain disorder that slowly damages nerve cells involved in movement. It affects millions of people around the world and becomes more common with age. The disease is ...

Researchers at the Icahn School of Medicine at Mount Sinai have found that patients with Parkinson's disease undergoing deep ...

CDC reports show Ohio's Parkinson's death rate among adults 65 and older was lower than Utah's 102.1 per 100,000 but remains ...

In a world first Australian researchers will test a one-off therapy that could replace damaged brain cells in people with ...

On June 29, at the 12 th Congress of the European Academy of Neurology (EAN) 2026, NeuroDerm presented post hoc analysis from ...

The Jam's Bruce Foxton has been diagnosed with Parkinson's Disease. Bassist Bruce, 70, took to Facebook to reveal the ...